Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer.

NPJ Precis Oncol · 2022 · PMC9630314 · PMID 36323882

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a positive trendp = 0.06so close (0.05 < p ≤ 0.1)

In 10 patient-derived xenograft (PDX) models of castration-resistant prostate cancer (LuCaP PDX series) 22 , we detected B7-H3 expression in each PDX tumor pair and found a positive trend between mRNA and protein expression ( n = 10, r = 0.52, p = 0.06) (Supplementary Figs. 1b –c and 4 ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.